Editors and Editorial Board
Editor-in-Chief
James B. Yu, MD, MHS. FASTRO
Smilow Cancer Hospital at Saint Francis Hospital
Editor-in-Chief
James B. Yu MD MHS FASTRO is a practicing radiation oncologist at Smilow Cancer Hospital at Saint Francis Hospital in Hartford, CT. He is a former Professor of Radiation Oncology at the Yale School of Medicine and Associate Chief Medical Officer of the Smilow Cancer Hospital and Care Centers. He was most recently the Executive Vice Chair of Columbia University Irving Medical Center Department of Radiation Oncology. As a member of the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, Dr. Yu’s research centers on the comparative effectiveness of new radiation technologies and how these new technologies are adopted nationally. He co-edited the textbook Principles of Clinical Cancer Research and over 300 peer reviewed manuscripts.
Editorial experience:
JNCI Cancer Spectrum, Editor in Chief (2024- ), Practical Radiation Oncology, Deputy Editor-In-Chief (2021- ), Senior Editor (2014-2021), Journal of Clinical Oncology - Clinical Cancer Informatics, Editorial Board (2016- ), JNCI, Editorial Board (2017- ), European Urology – Oncology, Editorial Board (2017-2021), Journal of Surgical Oncology, Editorial Board (2012 -), and Oncology (Williston Park), Editorial Board (2011- ), Journal of Clinical Oncology, Editorial Board (2014-2019).
Honors and awards include:
Fellow, American Society for Radiation Oncology (2023), Smilow Luminary Award of Excellence: Leadership (2020), Yale Cancer Center Research Prize (2013, 2017), Altmetric Top 10 Article (2018)
Deputy Editor
Matthew F. Hudson
Prisma Health, US
Matthew F. Hudson is Director of Cancer Care Delivery Research at Prisma Health and Professor of Medicine at the University of South Carolina School of Medicine Greenville. He holds leadership positions with multiple National Cancer Institute-affiliated groups, including the Community Oncology Research Program, the Consortium for Cancer Implementation Science, and the Comprehensive Oncologic Emergencies Research Network. Dr. Hudson also served on the National Academies of Science Engineering and Medicine’s committee examining the use of race and ethnicity in biomedical research. He also served on the Patient Centered Outcomes Research Institute’s (PCORI) Patient Engagement Advisory Panel.
Martin Stockler
NHMRC Clinical Trials Centre, University of Sydney
Martin Stockler is Professor of Oncology and Clinical Epidemiology at The University of Sydney, Consultant Medical Oncologist at Concord and Chris O’Brien Lifehouse Cancer Centres, and Director of Oncology at the NHMRC Clinical Trials Centre. After internal medicine and medical oncology training in Sydney, Australia, he spent 3 years training in clinical research methods at the Princess Margaret Hospital and University of Toronto in Canada. His research focuses on clinical trials to improve survival, quality of life, prognostication, and doctor-patient communication for those affected by cancer.
Associate Editors
Sanjay Aneja, MD
Yale School of Medicine, US
Jorge Barriuso, MD, PhD, MSc
Hospital Universitario 12 de Octubre, Spain
Traci N. Bethea, PhD, MPA
Georgetown Lombardi Comprehensive Cancer Center, USA
Justin Brown
Pennington Biomedical Research Center, US
Haryana Dhillon
University of Sydney, Australia
Daniel Haller
University of Pennsylvania, US
Thomas Hayman, MD, PhD
Yale University School of Medicine, US
Julian Hong, MD, MS
University of California San Francisco, US
Panos Konstantinopoulos
Dana Farber Cancer Institute, US
Shauna McVorran, MD, MHSA
Geisel School of Medicine at Dartmouth and the Dartmouth Cancer Center, US
Edwin Posadas
Cedars-Sinai Medical Center, US
Meredith Regan
Dana-Farber Cancer Institute, US
Shane Stecklein
University of Kansas Cancer Center, US
Leila Tchelebi
Janette Vardy
University of Sydney, Australia
Editorial Board
Marianne Berwick
University of New Mexico, USA
Prunella Blinman
University of Sydney, Australia
Harry Burke
Uniformed Services of the Health Sciences, USA
Rikki Cannioto
Roswell Park Cancer Institute, USA
Anne Cust
The Daffodil Centre, The University of Sydney and Cancel Council NSW, Australia
Michaela Dinan
Yale University Yale Cancer Center, USA
Lisa Gallicchio
National Cancer Institute, USA
Tara O. Henderson
University of Chicago Medical Center, USA
Jordan Holmes
Indiana University School of Medicine, USA
Aaron Katz
University of Kansas Medical Center, USA
Kim Jongphil
H. Lee Moffitt Cancer Center & Research Institute, USA
Amar Kishan
University of California Los Angeles, USA
Xiaoxian Li
Emory University, USA
Philip Lupo
Baylor College of Medicine, USA
Brigid Lynch
Cancer Council Victoria, Australia
Bruce Mann
The Royal Melbourne Hospital, Australia
Deborah K. Mayer
University of North Carolina, USA
Aaron Mitchell
Memorial Sloan Kettering Cancer Center, USA
Xinglei Shen
University of Kansas Medical Center, USA
David Shibata
University of Tennessee Health Science Center College of Medicine, USA
Logan Spector
University of Minnesota Twin Cities, USA
Susan Steck
University of South Carolina
Thomas Stinchcombe
Duke Cancer Center, USA
Fred Tabung
Ohio State University College of Medicine, USA
Lin Yang
Alberta Health Services, Canada
Tian Zhang
The University of Texas Southwestern Medical Center, USA
Statistical Editorial Board
Kellie J. Archer
The Ohio State University, USA
Ana Best
National Cancer Institute Division of Cancer Treatment and Diagnosis, USA
Ying Cao
University of Kansas Medical Center, USA
Christian Dehlendorff
Danish Medicines Council, Denmark
Todd DeWees
City of Hope, USA
Kevin Dobbin
University of Georgia College of Public Health, USA
May Kuo
The University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, USA
Gina L. Mazza
Mayo Clinic, USA
Anne Reiner
Memorial Sloan Kettering Cancer Center, USA
Lawrence V. Rubenstein
Biostatistics Branch, Biometric Research Program, USA
Qian Shi
Mayo Clinic, USA
Svitlana Tyekucheva
Dana-Farber Cancer Institute, USA
Editorial Staff
Managing Editor
Amanda Boehm
Peer Review Manager
Tina Belle
Inaugural Editor-in-Chief
Pamela J. Goodwin, MD, MSc
Mount Sinai Hospital, Canada
0000-0003-2637-6906
